Clinical Trial of New Insomnia Candidate - Arena Pharmaceuticals

Arena Pharmaceuticals, Inc announced today that it initiated dosing in a Phase 1 clinical trial for APD125, its novel drug candidate for the treatment of insomnia and the second Arena-discovered compound to enter the clinic this year... click link for more info.

Continue to Clinical Trial of New Insomnia Candidate - Arena Pharmaceuticals on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz